October 24, 2025
6,200
134
10
2.32%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
38:50
3:15Now PlayingA thirty-seven-year-old mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or even stop progression of the disease.
Emily Henders has had MS for four years, but existing drug treatments haven't worked, and three times she has woken to find she was unable to move her legs.
She was given an infusion of her own cells that had been weaponised in the lab to hunt down rogue elements in her immune system that drive the disease’s disabling relapses.
Sky News was given special permission to be present as the cells arrived deep-frozen in liquid nitrogen before being carefully thawed and infused into her bloodstream.
Sky's science and medical correspondent Thomas Moore reports.
#skynews #uk #multiplesclerosisawareness #ms #multiplesclerosis #experimental #drugtreatment
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our appsApple Android
Sky News Daily podcast is available for free here
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.